Inventor · disambiguated record
Wayne Spevak
Also filed as: SPEVAK WAYNE · SPEVAK WAYNE R
66 granted patents·30 pending applications·1,908 citations·filing 1996–2025
99Inventor score
Top patents by PatentIndex Score
96 records- 0199US9469640B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Oct 18, 2016·44 cites·12 claims
- 0298US8470818B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Jun 25, 2013·94 cites·56 claims
- 0398US8415469B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 9, 2013·84 cites·18 claims
- 0498US8198273B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Jun 12, 2012·65 cites·11 claims
- 0598US7863288B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2006·Granted Jan 4, 2011·187 cites·54 claims
- 0697US9844539B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 19, 2017·20 cites·30 claims
- 0797US9771369B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2015·Granted Sep 26, 2017·24 cites·18 claims
- 0897US8901301B2Pyrrolo[2,3-]pyridine kinase inhibitorsIBRAHIM PRABHA N·Filed 2010·Granted Dec 2, 2014·52 cites·7 claims
- 0997US8673928B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2010·Granted Mar 18, 2014·60 cites·15 claims
- 1097US8129404B2Compounds and uses thereofIBRAHIM PRABHA N·Filed 2010·Granted Mar 6, 2012·50 cites·6 claims
- 1197US7863289B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2007·Granted Jan 4, 2011·131 cites·24 claims
- 1297US7846941B2Compounds modulating c-kit and c-fms activity and uses thereforPLEXXIKON INC·Filed 2006·Granted Dec 7, 2010·92 cites·9 claims
- 1396US9822109B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2015·Granted Nov 21, 2017·23 cites·14 claims
- 1496US9776998B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2016·Granted Oct 3, 2017·20 cites·12 claims
- 1596US9771363B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2016·Granted Sep 26, 2017·34 cites·20 claims
- 1696US9617267B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Apr 11, 2017·38 cites·6 claims
- 1796US9440969B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Sep 13, 2016·40 cites·19 claims
- 1896US9096593B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Aug 4, 2015·34 cites·22 claims
- 1996US8153641B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA N·Filed 2009·Granted Apr 10, 2012·51 cites·8 claims
- 2096US8110576B2Substituted pyrrolo[2,3b]pyrazines and methods for treatment of raf protein kinase-mediated indicationsIBRAHIM PRABHA N·Filed 2009·Granted Feb 7, 2012·57 cites·15 claims
- 2195US10899761B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2020·Granted Jan 26, 2021·4 cites·6 claims
- 2295US10370374B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2018·Granted Aug 6, 2019·17 cites·22 claims
- 2395US9975894B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted May 22, 2018·20 cites·21 claims
- 2495US9814714B2Kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Nov 14, 2017·22 cites·31 claims
- 2595US9718847B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2014·Granted Aug 1, 2017·33 cites·21 claims
- 2695US9682981B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Jun 20, 2017·25 cites·14 claims
- 2795US9624213B2Compounds and methods for kinase modulation, and indications thereforIBRAHIM PRABHA·Filed 2012·Granted Apr 18, 2017·38 cites·4 claims
- 2895US8901118B2Compounds and methods for kinase modulation, and indications thereforZHANG JIAZHONG·Filed 2011·Granted Dec 2, 2014·53 cites·46 claims
- 2994US10160755B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Dec 25, 2018·15 cites·14 claims
- 3094US9994567B2Synthesis of heterocyclic compoundsPLEXXIKON INC·Filed 2017·Granted Jun 12, 2018·14 cites·7 claims
- 3194US9856259B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2015·Granted Jan 2, 2018·20 cites·20 claims
- 3293US9676748B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Jun 13, 2017·23 cites·20 claims
- 3393US8268858B2Compounds and methods for kinase modulation, and indications thereforWU GUOXIAN·Filed 2007·Granted Sep 18, 2012·49 cites·11 claims
- 3492US10426760B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2018·Granted Oct 1, 2019·6 cites·52 claims
- 3592US9938273B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2016·Granted Apr 10, 2018·17 cites·43 claims
- 3692US9873700B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2014·Granted Jan 23, 2018·20 cites·8 claims
- 3791US10647716B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2019·Granted May 12, 2020·7 cites·6 claims
- 3891US5962422AInhibition of selectin bindingUNIV CALIFORNIA·Filed 1997·Granted Oct 5, 1999·75 cites·38 claims
- 3989US10501460B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted Dec 10, 2019·6 cites·16 claims
- 4088US10703757B2Compounds and methods for CDK8 modulation and indications thereforPLEXXIKON INC·Filed 2017·Granted Jul 7, 2020·4 cites·38 claims
- 4188US10428067B2Compounds and methods for kinase modulationPLEXXIKON INC·Filed 2018·Granted Oct 1, 2019·8 cites·18 claims
- 4288US10421761B2Compounds for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Sep 24, 2019·6 cites·11 claims
- 4388US10301280B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted May 28, 2019·6 cites·21 claims
- 4488US5985852AInhibition of selectin bindingUNIV CALIFORNIA·Filed 1999·Granted Nov 16, 1999·67 cites·20 claims
- 4587US10160747B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 25, 2018·8 cites·25 claims
- 4685US10508085B2Compounds and methods for IDO and TDO modulation, and indications thereforPLEXXIKON INC·Filed 2017·Granted Dec 17, 2019·6 cites·37 claims
- 4785US2025195516A1Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2024·Application pending·0 cites
- 4884US10519177B2Heterocyclic compounds and uses thereofPLEXXIKON INC·Filed 2017·Granted Dec 31, 2019·4 cites·22 claims
- 4984US10227357B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2013·Granted Mar 12, 2019·7 cites·7 claims
- 5083US12076322B2Compounds and methods for kinase modulation, and indications thereforPLEXXIKON INC·Filed 2022·Granted Sep 3, 2024·0 cites·7 claims
Showing the top 50 of 96 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →